Edwards’ financials reveal that its transcatheter mitral and tricuspid therapies (TMTT) portfolio grew by 56.4% in 2025.

Mira’s integration with ŌURA allows its users to view sleep, readiness, and temperature trends alongside their hormone data ...

Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery ...

RWD and RWE are reshaping the design of clinical trials, making them smarter, faster, and more efficient. Read more here: ...

Asahi Kasei’s ZOLL has received approval for its Zenix monitor/defibrillator under the European Union Medical Device Regulation 2017/745.

In its Q1 fiscal 2026 financials, BD trimmed its EPS outlook by more than $2 at the high end due to the spin-off of its ...

GE HealthCare has announced the launch of ReadyFix, a remote fleet management solution designed to help healthcare systems optimise device uptime and maintain patient care, in the US.

TransMedics Group has received full and unconditional IDE approval from the US FDA for its next-generation OCS ENHANCE Heart ...

A jury ruled that Medtronic violated multiple antitrust laws over its use of restrictive contracts with healthcare providers ...

Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 LAA occluder, ...

Sonorous Neurovascular has received breakthrough device designation from the US FDA for its braided, self-expanding cerebral ...

Median’s FDA clearance proceeds the FDA clearance of RevealDX’s comparable tool for lung nodule evaluation on 3 February. The ...